BioCardia Inc (BCDA)
2.40
+0.01
(+0.42%)
USD |
NASDAQ |
Nov 04, 13:15
BioCardia Total Liabilities (Quarterly): 4.851M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 4.851M |
March 31, 2024 | 4.954M |
December 31, 2023 | 4.59M |
September 30, 2023 | 4.407M |
June 30, 2023 | 4.754M |
March 31, 2023 | 5.228M |
December 31, 2022 | 4.901M |
September 30, 2022 | 5.082M |
June 30, 2022 | 4.532M |
March 31, 2022 | 5.471M |
December 31, 2021 | 5.343M |
September 30, 2021 | 3.918M |
June 30, 2021 | 4.545M |
March 31, 2021 | 4.746M |
December 31, 2020 | 4.248M |
September 30, 2020 | 5.389M |
June 30, 2020 | 5.837M |
March 31, 2020 | 5.667M |
December 31, 2019 | 5.308M |
September 30, 2019 | 5.487M |
June 30, 2019 | 4.952M |
March 31, 2019 | 4.339M |
December 31, 2018 | 2.625M |
September 30, 2018 | 2.612M |
June 30, 2018 | 1.903M |
Date | Value |
---|---|
March 31, 2018 | 2.204M |
December 31, 2017 | 2.413M |
September 30, 2017 | 2.075M |
June 30, 2017 | 1.675M |
March 31, 2017 | 1.43M |
December 31, 2016 | 1.50M |
September 30, 2016 | 0.33M |
June 30, 2016 | 0.00 |
March 31, 2016 | 0.00 |
December 31, 2015 | 0.01M |
September 30, 2015 | 0.083M |
June 30, 2015 | 0.004M |
March 31, 2015 | 0.00 |
December 31, 2014 | 0.001M |
September 30, 2014 | 0.005M |
June 30, 2014 | 0.001M |
March 31, 2014 | 0.001M |
December 31, 2013 | 0.018M |
September 30, 2013 | 0.003M |
June 30, 2013 | 0.003M |
March 31, 2013 | 0.01M |
December 31, 2012 | 0.012M |
September 30, 2012 | 0.141M |
June 30, 2012 | 0.142M |
March 31, 2012 | 0.711M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
3.918M
Minimum
Sep 2021
5.837M
Maximum
Jun 2020
4.935M
Average
4.901M
Median
Dec 2022
Total Liabilities (Quarterly) Benchmarks
Alnylam Pharmaceuticals Inc | 4.173B |
Theriva Biologics Inc | 14.74M |
Zevra Therapeutics Inc | 111.93M |
PetIQ Inc | 634.08M |
Instil Bio Inc | 99.30M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 2.89M |
Shareholders Equity (Quarterly) | -1.961M |
Current Ratio | 0.3864 |